Hakki Ogün Sercan
Impact in
-
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Wnt/β-catenin signaling in development and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 1
-
- Wnt/β-catenin signaling in development and cancer 9
- Epigenetics and DNA Methylation 1
- Co-authors
- Jacomijn Petronella Dijksterhuis (1 shared paper)Rami N. Hannoush (1 shared paper)Gunnar Schulte (1 shared paper)Jeffrey S. Rubin (1 shared paper)Yun Ji (1 shared paper)Bolormaa Baljinnyam (1 shared paper)Karen Stanger (1 shared paper)Gülperi Öktem (2 shared papers)
- Journals
- Leukemia Research (3 papers)Oncology Reports (2 papers)Medical Oncology (1 paper)Tumor Biology (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- TürkiyeSwedenUnited States
In The Last Decade
Hakki Ogün Sercan
20 papers receiving 365 citations
Peers
Comparison fields: 5 of 38
- Hematology 53
- Molecular Biology 181
- Cancer Research 37
- Oncology 52
- Pathology and Forensic Medicine 20
Countries citing papers authored by Hakki Ogün Sercan
This map shows the geographic impact of Hakki Ogün Sercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakki Ogün Sercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakki Ogün Sercan more than expected).
Fields of papers citing papers by Hakki Ogün Sercan
This network shows the impact of papers produced by Hakki Ogün Sercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakki Ogün Sercan. The network helps show where Hakki Ogün Sercan may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakki Ogün Sercan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 132 | |
| 2 | 2014 | 48 | |
| 3 | 2014 | 46 | |
| 4 | 2009 | 37 | |
| 5 | 2002 | 21 | |
| 6 | 2010 | 16 | |
| 7 | 2000 | 14 | |
| 8 | 2017 | 10 | |
| 9 | 2007 | 9 | |
| 10 | 2009 | 9 | |
| 11 | 2004 | 7 | |
| 12 | 2022 | 7 | |
| 13 | 2017 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 1996 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2021 | 1 |
About Hakki Ogün Sercan
Hakki Ogün Sercan is a scholar working on Hematology, Molecular Biology, Cancer Research, Geriatrics and Gerontology and Oncology, having authored 21 papers that have together received 376 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Cancer Cells and Metastasis (2 papers), MicroRNA in disease regulation (2 papers), Epigenetics and DNA Methylation (1 paper), Acute Myeloid Leukemia Research (1 paper), Sirtuins and Resveratrol in Medicine (1 paper) and Growth Hormone and Insulin-like Growth Factors (1 paper). The work is most often cited by research in Hematology (53 citations), Molecular Biology (181 citations), Cancer Research (37 citations), Oncology (52 citations) and Pathology and Forensic Medicine (20 citations). Hakki Ogün Sercan has collaborated with scholars based in Türkiye, Sweden and United States. Frequent co-authors include Jacomijn Petronella Dijksterhuis, Rami N. Hannoush, Gunnar Schulte, Jeffrey S. Rubin, Yun Ji, Bolormaa Baljinnyam, Karen Stanger, Gülperi Öktem, Ayşegül Uysal and Şule Ayla. Their work appears in journals such as Leukemia Research, Oncology Reports, Medical Oncology, Tumor Biology and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.